News & Updates
Official announcements, product launches, and milestones from the WeDaita team.
Attended the Agentic Immunology Summit this past Thursday.
With nearly 10 years hands-on experience in immunology research during my PhD and postdoc training, and over a …
Read more
🚀 Selected for Harvard Business School Foundry Bootcamp — Advancing AI for Drug Discovery
Excited and honored to share that I’ve been selected for the Harvard Business School Foundry Bootcamp! 🚀 A …
Read more
BioMedAI 2.0 Beta is officially live!
If you are a researcher working in drug discovery and struggling with the haystack problem, BioMedAI can accelerate …
Read moreWeDaita v2.2.0 is live
Platform launch: Antibody Design, Deep Research, Competitive Landscape, Biomarker Discovery, Drug Repurposing, Target Prioritization, Pharmacovigilance, and Hypothesis Generation …
Read more
WeDaita is accepted into the NVIDIA Inception program.
WeDaita has been accepted into the NVIDIA Inception program.
Read more
ODSC East 2026 in Boston
As we gear up for the conference at the Hynes Convention Center, we are thrilled to announce that …
Read more
“Present Yourself in Public Speaking” 2-day intensive, immersive boot camp
Proud to share that I’ve completed the “Present Yourself in Public Speaking” 2-day intensive, immersive boot camp—an experience …
Read more
Pitch at the VC Breakfast hosted by MIT CSAIL
Great experience pitching WeDaita this morning at the VC Breakfast hosted by MIT CSAIL.
Read more
WeDaita selected as one of six premier startups to pitch to Samsung Ventures at the VC Breakfast
WeDaita has been selected as one of six premier startups to pitch to Samsung Ventures at the VC …
Read more
WeDaita Launches AI Scientists to Accelerate Drug Discovery
WeDaita has launched AI Scientists—24/7 intelligent research agents powered by advanced multimodal reasoning and disease-focused knowledge. Starting with …
Read more
WeDaita BioMedAI v2.0.0
WeDaita BioMedAI v2.0.0 is now live! This major update introduces 37,000+ lines of new code across 273 files, …
Read more